Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
Thursday, June 26, 2025Vor Bio Incand RemeGen Co Ltdtoday announced entry into an exclusive license agreement granting Vor Bio global rights excluding China Hong Kong Macau and Taiwan to develop and commercialize telitacicept a novel dualtarget fusion protein approved in C...
Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide)
Wednesday, June 25, 2025Starton Therapeutics Inc Starton a clinicalstage biotechnology company transforming standardofcare therapies with proprietary continuous delivery technologies today announced a collaboration agreement
Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine Journal
Wednesday, June 25, 2025Inventprise a clinical stage vaccine invention company today announced the publication of a landmark preclinical study in Vaccine Journal Vol April Article showcasing the potential of its novel bivalent
Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension (PAH)
Tuesday, June 24, 2025Merck known as MSD outside of the United States and Canada today announced positive topline results from the Phase HYPERION study evaluating WINREVAIR sotaterceptcsrk versus placebo
ORYZON Announces Submission of Phase III Protocol to FDA to Initiate PORTICO-2 Trial of Vafidemstat in Borderline Personality Disorder (BPD) Patients
Tuesday, June 24, 2025Oryzon Genomics SA a clinicalstage biopharmaceutical company and a European leader in epigenetics announced today that it has submitted the clinical trial protocol for its Phase III PORTICO trial to the US Food and Drug Administration
Candid Therapeutics Advances Portfolio of Novel T-Cell Engagers into Five Autoimmune Diseases for Clinical Evaluation
Saturday, June 21, 2025Candid Therapeutics Inc a clinicalstage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel Tcell engagers TCEs today announced key operational and clinical milestones
Exelixis’ Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors
Saturday, June 21, 2025Rt these new indications for patients in Europe and Exelixis scientific pursuit to create transformational treatments that give more patients hope for the future Any statements that refer to expec
Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France
Friday, June 20, 2025The life science group Sartorius today celebrates the completion of a multiyear capacity expansion project at the headquarters of its French subgroup Sartorius Stedim Biotech in Aubagne
Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia
Thursday, June 19, 2025Biogen Incannounced the initiation of dosing in the BRAVE study a global Phase clinical trial The BRAVE study will evaluate the efficacy and safety of omaveloxolone in children with Friedreich ataxia FA between the ages
MAIA Biotechnology Announces Master Clinical Supply Agreement with Roche for Hard-to-Treat Cancer Therapies
Thursday, June 19, 2025MAIA Biotechnology Inc a clinicalstage biopharmaceutical company focused on developing targeted immunotherapies for cancer today announced its entry into a clinical master supply agreement with Roche for future studies
